Literature DB >> 28011969

Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections.

Zahra Tayebi1, Hamid Heidari2, Hossein Kazemian3, Seyed Mohammad Ghafoori1, Shahram Boroumandi4, Hamidreza Houri5.   

Abstract

The growing frequency of antibiotic resistances is now a universal problem. Increasing resistance to new generations of β-lactam and quinolone antibiotics in multidrug-resistant Enterobacteriaceae isolates is considered an emergency health issue worldwide. The aim of this study was to evaluate plasmid-mediated quinolone resistance genes in ESBL-producing Escherichia coli isolated from urinary tract infections (UTIs). In our study ESBL-producing isolates were assessed by screening methods. After determination of antimicrobial susceptibility testing, detection of ESBLs and quinolone resistance genes was performed. A total of 97 ESBL-producing E. coli were determined. The bla-TEM, bla-SHV and bla-CTX-M genes were detected in 90 isolates. The bla-TEM was the most frequently detected gene (46.4%), followed by bla-SHV (31.9%) and bla-CTX-M (14.4%). The most prevalent quinolone resistance gene among ESBL-producing isolates was oqxAB which was found in 67 isolates (69.1%). The frequencies of the aac(6')-Ib-cr, qnr and qepA were 65 (67%), 8 (8.2%) and 6 (6.2%), respectively. Our data indicate that the prevalence of plasmid-mediated quinolone resistance genes in ESBL-positive isolates is increasing. The co-dissemination of PMQR and ESBL genes among E. coli isolates can be considered a threat to public health. Therefore, prescription of antibiotics against infectious disease should be managed carefully.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28011969

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  6 in total

1.  Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli Isolates.

Authors:  Hossein Kazemian; Hamid Heidari; Roya Ghanavati; Sobhan Ghafourian; Fateme Yazdani; Nourkhoda Sadeghifard; Hasan Valadbeigi; Abbas Maleki; Iraj Pakzad
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

2.  Prevalence and molecular characterization of oqxAB in clinical Escherichia coli isolates from companion animals and humans in Henan Province, China.

Authors:  Baoguang Liu; Hua Wu; Yajun Zhai; Zhipei He; Huarun Sun; Tian Cai; Dandan He; Jianhua Liu; Shanmei Wang; Yushan Pan; Li Yuan; Gongzheng Hu
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-02       Impact factor: 4.887

Review 3.  Delafloxacin: design, development and potential place in therapy.

Authors:  Francisco Javier Candel; Marina Peñuelas
Journal:  Drug Des Devel Ther       Date:  2017-03-20       Impact factor: 4.162

4.  Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran.

Authors:  Yalda Malekzadegan; Elham Rastegar; Melika Moradi; Hamid Heidari; Hadi Sedigh Ebrahim-Saraie
Journal:  Infect Drug Resist       Date:  2019-06-19       Impact factor: 4.003

5.  Characterization and Bio-Typing of Multidrug Resistance Plasmids From Uropathogenic Escherichia coli Isolated From Clinical Setting.

Authors:  Sandip Kumar Mukherjee; Mandira Mukherjee
Journal:  Front Microbiol       Date:  2019-12-18       Impact factor: 5.640

6.  Detection of Antimicrobial Susceptibility and Integrons Among Extended-spectrum β-lactamase Producing Uropathogenic Escherichia coli Isolates in Southwestern Iran.

Authors:  Hadi Sedigh Ebrahim-Saraie; Niloofar Zahedian Nezhad; Hamid Heidari; Ashkan Motamedifar; Mohammad Motamedifar
Journal:  Oman Med J       Date:  2018-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.